Abstract
This essay advances the market from managing stated balances to evaluating expected recoverable value. It introduces the ARxCurve™, an economic optimization curve that identifies the point at which patient fit and provider revenue are most closely aligned.
Introduction
The first essay in this series established that patient financial performance is not primarily an RCM execution problem—or one that execution alone can solve. It is an economic decisioning problem. This essay advances that premise by asking the practical question it creates: If the balance is not the strategy, how should the market determine the right path for each patient encounter?
A practical economic response is a Patient-Provider Revenue Curve—an application of economic optimization methods used across complex markets and reconfigured by ARxChange for patient financial performance. Applied here, the curve reframes the patient balance from a fixed amount to be pursued into one input within a broader revenue decision: which available pathway offers the strongest patient fit and greatest expected provider value.
The Balance Is the Obligation—Not the Strategy
Healthcare has long treated the patient balance as the operating fact. Once a balance exists, systems begin acting on it: statement, reminder, portal, call, payment plan, financing, collection agency, hardship review, or write-off.
That sequence may be familiar, but it is economically incomplete.
A $1,000 patient balance is not automatically more valuable than a $250 balance. A high-balance account with a 5% probability of payment may carry less economic value than a lower-balance account with a 50% probability of payment.
That is the core insight: healthcare often manages the face value of the balance when it should be managing expected yield.
What the Patient-Provider Revenue Curve Calculates: Net Expected Recoverable Patient Revenue
The Patient-Provider Revenue Curve gives structure to the central economic question: not what balance is owed, but what revenue is realistically recoverable—and through which path.
At its center is Net Expected Recoverable Patient Revenue: the highest attainable provider value after accounting for balance size, patient capacity, probability of payment, timing, cost to pursue, pathway fit, and expected realization.
This is not a propensity score, an affordability indicator, or a collection ranking. Those are inputs. The curve evaluates how those inputs interact across competing revenue scenarios—payment in full, payment terms, financing, assistance, continued pursuit, or resolution—and estimates the net value of each.
How the Curve Works
The curve identifies the revenue inflection point for each encounter—the point at which patient-payment fit and provider realization are jointly optimized.
Its central principle is well established in economics: charging more, pursuing harder, or increasing financial pressure does not always produce more revenue. The Laffer Curve offers the closest analogy. Tax revenue may rise as rates increase, but only to a point; beyond it, higher rates can alter behavior, increase avoidance, and reduce total revenue. [1]
Patient-pay follows the same logic. A higher balance, larger monthly payment, more intensive collection strategy, or more expensive financing option may preserve value on paper while reducing actual realization by lowering payment probability, increasing cost, delaying resolution, or pushing the patient out of the payment path entirely.
In this model, the balance is the stated obligation, the patient's decision is the behavioral response, and provider revenue is the realized return.
Applying the Curve
The optimization curve begins with six domains of financial intelligence: account economics, affordability and capacity, financial stress, coverage opportunity, assistance and hardship eligibility, and payment behavior and engagement. Economic Intelligence converts those signals into 48 normalized behavioral-economic segments—much as clinical classification systems translate complex information into more precise, standardized categories.
It then compares the viable pathways for each segment against the provider's available engagement assets, operational resources, and resolution capabilities—payment in full, tailored terms, financing, assistance, continued pursuit, or resolution—and estimates the effect of each on patient response, cost, timing, and provider yield. The pathway is selected based on economic fit, rather than availability or billing-cycle timing, to identify where patient fit and provider realization are most closely aligned.
Drawing on the logic of economic equilibrium and Pareto efficiency, [2] the ARxCurve™ compares competing financial pathways to identify the strongest attainable patient-provider outcome—maximizing the probability-adjusted value that can realistically be converted rather than balance size, financial pressure, or collection intensity.
Published HFMA research involving approximately 785,000 accounts across 200 facilities illustrates the curve’s governing principle: economically optimized financial assistance increased estimated per-account revenue by 83% for uninsured patients and 22% for insured patients. [3] The finding demonstrates that reducing the patient obligation can, under the right conditions, increase rather than sacrifice expected revenue.
Market-Forward
The ARxCurve™ moves patient financial performance from activity management to economic optimization by replacing face value as the primary measure of revenue opportunity with Net Expected Recoverable Patient Revenue—aligning balance, capacity, payment probability, cost, and pathway around the outcome most likely to produce realized value. It sits upstream of engagement, payment, financing, collections, hardship resolution, analytics, and workflow—not to replace those tools, but to determine which should be used, for whom, and under what economic condition, including when compliant balance or term redesign may produce greater expected provider revenue than continued pursuit of the original obligation.
References
- The Laffer Curve, as commonly used in tax policy, describes the theoretical relationship between tax rates and total tax revenue, including the possibility that revenue can decline when rates move beyond a revenue-maximizing point.
- See Vilfredo Pareto, Manual of Political Economy, which helped establish modern economic-efficiency analysis, and Kenneth J. Arrow and Gérard Debreu, "Existence of an Equilibrium for a Competitive Economy," Econometrica 22, no. 3 (1954): 265–290. Pareto efficiency refers to a condition in which no available reallocation can improve one party's position without diminishing another's; competitive-equilibrium analysis examines how interacting preferences, constraints, and alternatives settle into a balanced outcome.
- Zadoorian, James A., Thomas Bernardin, and Ashley Hodgson. "Patient-Centric Aid in a Consumer-Driven Marketplace." hfm Magazine, December 2018.
The Series